One of the significant clinical manifestations COVID-19 is thrombosis in different circulatory beds, most commonly within pulmonary vasculature. Pathogenesis this complication has not yet been elucidated, though some autopsy reports have shown high prevalence microthrombi various organs, including lungs, kidney, and heart.[1] [2] these suggested possibility circulating megakaryocytes (MKs) as b...